Athira Pharma logo

Athira Pharma Share Price Today

(NASDAQ: ATHA)

Athira Pharma share price is $0.24 & ₹20.51 as on 18 Apr 2025, 2.30 'hrs' IST

$0.24

0.01

(4.37%)

Market is closed - opens 7 PM, 21 Apr 2025

View live Athira Pharma share price in Dollar and Rupees. Guide to invest in Athira Pharma stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Athira Pharma, along with analyst recommendations, forecasts, and comprehensive financials.

Athira Pharma share price movements

  • Today's Low: $0.22
    Today's High: $0.24

    Day's Volatility :8.33%

  • 52 Weeks Low: $0.22
    52 Weeks High: $3.67

    52 Weeks Volatility :94.02%

Athira Pharma (ATHA) Returns

PeriodAthira Pharma IncSector (Health Care)Index (Russel 2000)
3 Months
-55.68%
-2.8%
0.0%
6 Months
-47.71%
-11.0%
0.0%
1 Year
-88.78%
-1.9%
0.0%
3 Years
-97.97%
-1.5%
-12.9%

Athira Pharma (ATHA) Key Statistics

in dollars & INR

Previous Close
$0.229
Open
$0.2363
Today's High
$0.24
Today's Low
$0.22
Market Capitalization
$9.3M
Today's Volume
$51.6K
52 Week High
$3.67
52 Week Low
$0.219549
Revenue TTM
$0.0
EBITDA
$-95.8M
Earnings Per Share (EPS)
$-2.52
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-110.77%

How to invest in Athira Pharma Stock (ATHA) from India?

It is very easy for Indian residents to invest directly in Athira Pharma from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Athira Pharma stock in both Indian Rupees (INR) and US Dollars (USD). Search for Athira Pharma or ATHA on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Athira Pharma or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Athira Pharma shares which would translate to 3.561 fractional shares of Athira Pharma as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Athira Pharma, in just a few clicks!

Returns in Athira Pharma (ATHA) for Indian investors in Rupees

The Athira Pharma stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Athira Pharma investment value today

Current value as on today

₹13,609

Returns

₹86,391

(-86.39%)

Returns from Athira Pharma Stock

₹88,732 (-88.73%)

Dollar Returns

₹2,341 (+2.34%)

Indian investors sentiment towards Athira Pharma (ATHA)

2%

Period: Mar 19, 2025 to Apr 18, 2025. Change in 30 Days versus previous period

Search interest for Athira Pharma Stock from India on INDmoney has increased by 2% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Athira Pharma

  • Perceptive Advisors LLC

    13.84%

  • BML Capital Management LLC

    7.11%

  • Vanguard Group Inc

    3.99%

  • Propel Bio Management LLC

    3.82%

  • Simplify Asset Management Inc.

    3.82%

  • TANG CAPITAL MANAGEMENT LLC

    1.54%

Analyst Recommendation on Athira Pharma

Rating
Trend

Buy

    66%Buy

    33%Hold

    0%Sell

Based on 12 Wall street analysts offering stock ratings for Athira Pharma(by analysts ranked 0 to 5 stars)

Analyst Forecast on Athira Pharma Stock (ATHA)

What analysts predicted

Upside of 129.17%

Target:

$0.55

Current:

$0.24

Insights on Athira Pharma Stock (Ticker Symbol: ATHA)

  • Price Movement

    In the last 7 days, ATHA stock has moved down by -8.4%
  • ATHA vs ONC (1 yr)

    In the last 1 year, Beone Medicines Ltd has given 76.1% return, outperforming this stock by 165.3%
  • ATHA vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 28.9% return, outperforming this stock by 126.9%

Athira Pharma Technicals Summary

Sell

Neutral

Buy

Athira Pharma is currently in a neutral trading position according to technical analysis indicators.

Athira Pharma (ATHA) Vs Peers

Returns
Ratio's
Overview
Company Name1 Month6 Month1 Year3 Years5 Years
Athira Pharma Inc logo
-30.35%
-47.71%
-88.78%
-97.97%
-98.6%
Regeneron Pharmaceuticals, Inc. logo
-17.1%
-41.85%
-37.2%
-21.74%
-0.85%
Beone Medicines Ltd logo
-13.12%
5.03%
78.34%
40.23%
43.44%
Vertex Pharmaceuticals Incorporated logo
-4.76%
2.3%
24.05%
71.43%
78.99%
Alnylam Pharmaceuticals, Inc. logo
-9.09%
-19.67%
62.43%
39.66%
61.91%

About Athira Pharma

Athira Pharma, Inc., clinical-stage biopharmaceutical company, focuses on developing small molecules to restore neuronal health and slow neurodegradation. Its product pipeline includes ATH-1105 for the treatment of amyotrophic lateral sclerosis, which is in phase 1 clinical trial; ATH-1020 for the treatment of neurodegenerative diseases, which is phase 1 clinical trial, as well as early compounds which is in preclinical phase. The company was formerly known as M3 Biotechnology, Inc. and changed its name to Athira Pharma, Inc. in April 2019. Athira Pharma, Inc. was incorporated in 2011 and is headquartered in Bothell, Washington.
Organization
Athira Pharma
Employees
26
CEO
Dr. Mark J. Litton M.B.A., Ph.D.
Industry
Commercial Services

Management People of Athira Pharma

NameTitle
Dr. Mark J. Litton M.B.A., Ph.D.
President, CEO & Director
Dr. Javier San Martin M.D.
Chief Medical Officer

Important FAQs about investing in ATHA Stock from India :

What is Athira Pharma share price today?

Athira Pharma share price today stands at $0.24, Open: $0.24 ; Previous Close: $0.23 ; High: $0.24 ; Low: $0.22 ; 52 Week High: $3.67 ; 52 Week Low: $0.22.

The stock opens at $0.24, after a previous close of $0.23. The stock reached a daily high of $0.24 and a low of $0.22, with a 52-week high of $3.67 and a 52-week low of $0.22.

Can Indians buy Athira Pharma shares?

Yes, Indians can invest in the Athira Pharma (ATHA) from India.

With INDmoney, you can buy Athira Pharma at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Athira Pharma at zero transaction cost.

How can I buy Athira Pharma shares from India?

It is very easy to buy Athira Pharma from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Athira Pharma (ATHA) be purchased?

Yes, you can buy fractional shares of Athira Pharma with INDmoney app.

What are the documents required to start investing in Athira Pharma stocks?

To start investing in Athira Pharma, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Athira Pharma Stock (ATHA)?

Today’s highest price of Athira Pharma (ATHA) is $0.24.

Today’s lowest price of Athira Pharma (ATHA) is $0.22.

What is today's market capitalisation of Athira Pharma?

Today's market capitalisation of Athira Pharma ATHA is 9.3M

What is the 52 Week High and Low Range of Athira Pharma Stock (ATHA)?

  • 52 Week High

    $3.67

  • 52 Week Low

    $0.22

What are the historical returns of Athira Pharma (ATHA)?

  • 1 Month Returns

    -30.35%

  • 3 Months Returns

    -47.71%

  • 1 Year Returns

    -88.78%

  • 5 Years Returns

    -98.6%

Who is the Chief Executive Officer (CEO) of Athira Pharma ?

Dr. Mark J. Litton M.B.A., Ph.D. is the current Chief Executive Officer (CEO) of Athira Pharma.